China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · Real-Time Price · USD
0.450
+0.044 (10.95%)
At close: Dec 26, 2024, 4:00 PM
0.466
+0.016 (3.56%)
After-hours: Dec 26, 2024, 5:44 PM EST
China SXT Pharmaceuticals Employees
China SXT Pharmaceuticals had 75 employees as of March 31, 2024. The number of employees decreased by 3 or -3.85% compared to the previous year.
Employees
75
Change (1Y)
-3
Growth (1Y)
-3.85%
Revenue / Employee
$25,713
Profits / Employee
-$41,314
Market Cap
1.56M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Scorpius Holdings | 84 |
| Molecular Templates | 62 |
| cbdMD | 52 |
| Cyclacel Pharmaceuticals | 12 |
| TransCode Therapeutics | 10 |
| Revelation Biosciences | 9 |
| Virpax Pharmaceuticals | 7 |
| Aclarion | 6 |
SXTC News
- 2 months ago - China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency - GlobeNewsWire
- 1 year ago - China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq's Minimum Bid Price Rule - GlobeNewsWire
- 1 year ago - China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split - GlobeNewsWire
- 2 years ago - China SXT Pharmaceuticals, Inc. Announces 1 for 20 Reverse Share Split - GlobeNewsWire
- 3 years ago - China SXT Pharmaceuticals, Inc. Enters into Securities Purchase Agreement to Issue a 6% Convertible Promissory Note in the Original Principal Amount of $2.8 Million - GlobeNewsWire
- 3 years ago - Aegis Capital Corp. Acted as Sole Bookrunner on a $4.1 Million Underwritten Public Offering of Ordinary Shares, Inclusive of the Over-Allotment, for China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC). - Accesswire
- 3 years ago - China SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-Allotment - GlobeNewsWire
- 3 years ago - China SXT Pharmaceuticals, Inc. Prices $3.5 Million Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares - GlobeNewsWire